$69.270
-2.438 (-3.52%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MNPR Prediction & Forecast by Similar Chart Analysis
Alphio's MNPR stock price prediction model matches the current Monopar Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $69.30 (+0.05%). The 1-week path is $71.31 (+2.94%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Monopar Therapeutics Inc Stock?
Monopar Therapeutics Inc is not a good buy right now due to its current price of $69.27, which is significantly below the analyst price target of $145 from Barclays. Additionally, the stock has a very low RSI of 17.804, indicating it is oversold, but the negative earnings trend with a forward P/E of 0 and a net income loss of -5,313,300 USD in Q2 2026 raises concerns about its financial health. The main risk is the continued negative earnings trend, with losses expected to persist in the coming quarters.
MNPR stock price ended at $69.27 on Friday, after losing -3.52%
Monopar Therapeutics Inc (MNPR) last closed at $69.27, losing -3.52%. These facts feed the 1-day and 1-week MNPR price prediction above.
Forecast Drivers
Monopar Therapeutics Inc (MNPR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MNPR, ranked by similarity.
Seasonality analysis for MNPR
Historically the probability of a positive October return for MNPR is 100.00%. July offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MNPR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $49.44 | $49.76 | $51.59 | -28.16% |
| Nov 2026 | $37.98 | $45.86 | $55.22 | -33.80% |
| Dec 2026 | $33.98 | $42.59 | $43.27 | -38.52% |
In 2026, Monopar Therapeutics Inc (MNPR) is projected to range from $33.98 to $55.22.
Monopar Therapeutics Inc 2026 monthly forecast
In Oct 2026, Monopar Therapeutics Inc is projected to average $49.76, with a low of $49.44 and high of $51.59.
In Nov 2026, Monopar Therapeutics Inc is projected to average $45.86, with a low of $37.98 and high of $55.22.
In Dec 2026, Monopar Therapeutics Inc is projected to average $42.59, with a low of $33.98 and high of $43.27.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.